首页 正文

Recent Update on Immunotherapy and Its Combination With Interventional Therapies for Hepatocellular Carcinoma

{{output}}
Hepatocellular carcinoma (HCC) is one of the most common and deadly malignancies worldwide. Approximately, 80% of patients are initially diagnosed at intermediate or advanced stages, which means that curative therapies are unable to be performed. In most cases... ...